Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,300 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
Cambrex offers a range of specialized drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid-state science, material characterization, stability storage and testing and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
drug substance services, drug product services, analytical services
Salesforce, Mailchimp Mandrill, Outlook, Pardot, Microsoft Office 365, Drupal, SharpSpring, iCIMS, Atlassian Cloud, Google Font API, Vimeo, LeadForensics, New Relic, Facebook Login (Connect), Mobile Friendly, AddThis, Multilingual, Perfect Audience, WordPress.org, Nginx, Linkedin Marketing Solutions, Google Tag Manager